 |
English
|
正體中文
|
简体中文
|
全文筆數/總筆數 : 29490/55136 (53%)
造訪人次 : 1551974
線上人數 : 300
|
|
|
資料載入中.....
|
請使用永久網址來引用或連結此文件:
http://ir.cmu.edu.tw/ir/handle/310903500/30835
|
| 題名: | Induction of G(0)/G(1) arrest and apoptosis by 3-hydroxycinnamic acid in human cervix epithelial carcinoma (HeLa) cells |
| 作者: | Chuang, JY;Tsai, YY;Chen, SC;Hsieh, TJ;Chung, JG |
| 貢獻者: | 醫學院醫學系微生物學科;China Med Univ, Dept Microbiol, Taichung 40402, Taiwan;China Med Univ, Sch Med Lab Sci & Biotechnol, Taichung 40402, Taiwan;Natl Kaohsiung Normal Univ, Dept Biotechnol, Kaohsiung, Taiwan;Dept Med Technol, Kaohsiung, Taiwan |
| 日期: | 2005 |
| 上傳時間: | 2010-09-24 15:02:51 (UTC+8) |
| 出版者: | INT INST ANTICANCER RESEARCH |
| 摘要: | Cerebrospinal fluid (CSF) amino acid concentrations were measured in 45 children with acute lymphoblastic leukemia (ALL). Central nervous system (CNS) disease was absent in 34 and present in 11 (Groups L and M, respectively) at diagnosis. Thirty-two otherwise healthy children with febrile convulsions were studied for comparison. Results from this study show that glutamine levels at Day 0 were significantly higher in patients than in controls. Patients in Group M had elevated glutamine levels compared to Group L. In comparison, at Day 14, concentrations of glutamine and asparagine decreased, while glutamic acid amounts increased significantly in Group L. Glutamine levels fell at Day 42 in Group M, which may have resulted from more intensive treatment. From this study we hypothesise that higher baseline glutamine levels are indicative of a greater risk for CNS leukemia. Large-scale prospective trials are required to confirm increased baseline CSF glutamine levels in ALL patients, to identify glutamine as a marker for CNS disease and to clarify underlying mechanisms regulating glutamine in ALL. (c) 2005 Elsevier Ltd. All rights reserved. |
| 關聯: | IN VIVO 19(4):683-688 |
| 顯示於類別: | [醫學系] 期刊論文
|
在CMUR中所有的資料項目都受到原著作權保護.
|
